Compound Detail
CHEMBL71
CHLORPROMAZINE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL71 |
| Name | CHLORPROMAZINE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | ZPEIMTDSQAKGNT-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
101
Targets
303
Activities
4
Assay Types
30
PK Parameters
20
Publications
18
Known Names
11
Indications
2
Mechanisms
Molecular Properties
318.9
MW (Da)
4.89
ALogP
3
HBA
0
HBD
6.5
PSA (Ų)
0.79
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 1957 |
| Availability | Prescription |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Serotonin 2a (5-HT2a) receptor antagonist | ANTAGONIST | 5-hydroxytryptamine receptor 2A | ✓ | ✓ |
| D2-like dopamine receptor antagonist | ANTAGONIST | D2-like dopamine receptor | ✓ | ✓ |
Indications
Conduct Disorder Porphyrias Postoperative Nausea and Vomiting Psychotic Disorders Psychotic Disorders Schizophrenia Neonatal Abstinence Syndrome Severe Acute Respiratory Syndrome Delirium Glioblastoma Colonic Neoplasms
ATC Classification
N05AA01
chlorpromazine
Level 1: NERVOUS SYSTEM
Level 2: PSYCHOLEPTICS
Activity Summary
IC50 153 meas. best 9.0
Ki 137 meas. best 9.15
EC50 7 meas. best 5.7
Kd 6 meas. best 6.74
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | Ki | 9.15 | 8.7033 | 0.7 | 3 |
| D(2) dopamine receptor CHEMBL217 | IC50 | 9.0 | 8.342 | 1.0 | 5 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | Ki | 8.96 | 8.308 | 1.1 | 5 |
| D(2) dopamine receptor CHEMBL217 | Ki | 8.92 | 8.3867 | 1.2 | 9 |
| D(2) dopamine receptor CHEMBL339 | Ki | 8.92 | 8.396 | 1.2 | 10 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | Ki | 8.8 | 8.53 | 1.6 | 2 |
| D(3) dopamine receptor CHEMBL234 | Ki | 8.8 | 8.2827 | 1.6 | 11 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 8.71 | 8.71 | 2.0 | 1 |
| Histamine H1 receptor CHEMBL231 | Ki | 8.71 | 8.54 | 2.0 | 2 |
| D(1A) dopamine receptor CHEMBL265 | IC50 | 8.67 | 8.67 | 2.1 | 1 |
| Unchecked CHEMBL612545 | Ki | 8.57 | 7.1453 | 2.7 | 15 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | Ki | 8.56 | 7.714 | 2.7 | 5 |
| 5-hydroxytryptamine receptor 2A CHEMBL224 | IC50 | 8.47 | 8.44 | 3.4 | 2 |
| Alpha-1A adrenergic receptor CHEMBL319 | Ki | 8.46 | 8.46 | 3.5 | 1 |
| Alpha-1D adrenergic receptor CHEMBL223 | IC50 | 8.4 | 8.4 | 4.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | Ki | 8.4 | 7.544 | 4.0 | 5 |
| Alpha-1B adrenergic receptor CHEMBL315 | Ki | 8.3 | 8.3 | 5.0 | 1 |
| 5-hydroxytryptamine receptor 2C CHEMBL225 | IC50 | 8.28 | 8.28 | 5.2 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | IC50 | 8.07 | 8.07 | 8.5 | 1 |
| Serotonin 2 (5-HT2) receptor CHEMBL2093870 | IC50 | 8.06 | 8.06 | 8.8 | 1 |
| Alpha-1B adrenergic receptor CHEMBL315 | IC50 | 8.05 | 8.05 | 9.0 | 1 |
| Dopamine receptor CHEMBL2093868 | IC50 | 8.01 | 7.3555 | 9.9 | 11 |
| 5-hydroxytryptamine receptor 7 CHEMBL3155 | Ki | 7.97 | 7.4733 | 10.7 | 6 |
| Alpha-2B adrenergic receptor CHEMBL1942 | Ki | 7.92 | 7.92 | 12.0 | 1 |
| Histamine H1 receptor CHEMBL231 | IC50 | 7.92 | 7.845 | 12.0 | 2 |
| D(3) dopamine receptor CHEMBL234 | IC50 | 7.92 | 7.92 | 12.0 | 1 |
| Dopamine receptor CHEMBL2093868 | Ki | 7.85 | 7.85 | 14.0 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | Ki | 7.75 | 7.75 | 18.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | IC50 | 7.72 | 7.72 | 19.0 | 1 |
| Sodium-dependent noradrenaline transporter CHEMBL222 | Ki | 7.72 | 7.72 | 19.0 | 1 |
| Muscarinic acetylcholine receptor M1 CHEMBL216 | Ki | 7.7 | 7.3 | 20.0 | 2 |
| Muscarinic acetylcholine receptor M4 CHEMBL1821 | Ki | 7.68 | 7.24 | 21.0 | 2 |
| Sodium-dependent serotonin transporter CHEMBL228 | Ki | 7.68 | 7.44 | 21.0 | 2 |
| 5-hydroxytryptamine receptor 7 CHEMBL3223 | Ki | 7.68 | 7.68 | 21.0 | 1 |
| Muscarinic acetylcholine receptor M5 CHEMBL2035 | IC50 | 7.6 | 7.6 | 25.0 | 1 |
| Dopamine receptor CHEMBL2096970 | IC50 | 7.6 | 7.0675 | 25.0 | 4 |
| D(4) dopamine receptor CHEMBL219 | Ki | 7.6 | 7.235 | 25.1 | 4 |
| Alpha-2B adrenergic receptor CHEMBL1942 | IC50 | 7.58 | 7.58 | 26.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL1907610 | IC50 | 7.51 | 7.51 | 31.0 | 2 |
| Unchecked CHEMBL612545 | IC50 | 7.47 | 5.521 | 34.0 | 20 |
| D(1A) dopamine receptor CHEMBL265 | Ki | 7.46 | 7.4033 | 35.0 | 3 |
| Sodium-dependent serotonin transporter CHEMBL228 | IC50 | 7.41 | 7.165 | 39.0 | 2 |
| 5-hydroxytryptamine receptor 2B CHEMBL1833 | Ki | 7.4 | 7.26 | 39.8 | 3 |
| D(2) dopamine receptor CHEMBL339 | IC50 | 7.4 | 7.4 | 40.0 | 2 |
| Muscarinic acetylcholine receptor M3 CHEMBL245 | Ki | 7.36 | 7.36 | 44.0 | 1 |
| Histamine H1 receptor CHEMBL3943 | Ki | 7.3 | 7.3 | 50.1 | 1 |
| Rattus norvegicus CHEMBL376 | IC50 | 7.29 | 7.02 | 51.0 | 2 |
| Alpha-2C adrenergic receptor CHEMBL1916 | Ki | 7.27 | 7.27 | 54.0 | 1 |
| 5-hydroxytryptamine receptor 6 CHEMBL3371 | IC50 | 7.24 | 7.24 | 57.0 | 1 |
| Muscarinic acetylcholine receptor CHEMBL1907609 | Ki | 7.22 | 7.22 | 60.3 | 2 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 117.0 | mL.min-1.g-1 | Homo sapiens |
| CL | 8.6 | mL.min-1.kg-1 | Homo sapiens |
| CL | 16.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 15.8 | mL.min-1.kg-1 | Homo sapiens |
| CL | 16.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 53.0 | mL.min-1.kg-1 | Canis lupus familiaris |
| CL | 61.0 | mL.min-1.kg-1 | Rattus norvegicus |
| CL | 4.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 16.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 24.6 | mL.min-1.kg-1 | Macaca |
| CL | 14.45 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 37.15 | mL.min-1.g-1 | Homo sapiens |
| CL | 150.0 | uL.min-1.(10^6cells)-1 | Rattus norvegicus |
| CL | 278.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 82.5 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 252.2 | uL.min-1.(10^6cells)-1 | Homo sapiens |
| CL | 14000.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 1.0 | mL.min-1.kg-1 | Homo sapiens |
| CL | 18.3 | mL.min-1.kg-1 | Homo sapiens |
| CL | 8.6 | mL.min-1.kg-1 | Homo sapiens |
| F | 49.0 | % | Homo sapiens |
| F | 32.0 | % | Homo sapiens |
| Fu | 0.03 | - | - |
| Fu | 0.001 | - | - |
| Fu | 0.03 | - | Homo sapiens |
| Fu | 0.056 | - | Homo sapiens |
| Fu | 0.056 | - | Homo sapiens |
| Fu | 0.003 | - | Homo sapiens |
| Fu | 0.002 | - | Rattus norvegicus |
| Fu | 0.0022 | - | Sus scrofa |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| - | 10.6019/CHEMBL3885861 | Rattus norvegicus | 1218 |
| - | 10.6019/CHEMBL3885881 | Rattus norvegicus | 458 |
| 28964936 | 10.1016/j.ejmech.2017.09.014 | Unchecked | 186 |
| 2571727 | 10.1021/jm00130a003 | Mus musculus | 26 |
| - | 10.6019/CHEMBL4295262 | Unchecked | 24 |
| 18694955 | 10.1128/aac.00661-08 | NON-PROTEIN TARGET | 19 |
| 22194678 | 10.1371/journal.pcbi.1002310 | Hepatotoxicity | 14 |
| 35707966 | 10.1021/acs.jnatprod.2c00376 | ADMET | 14 |
| 6167716 | 10.1021/jm00135a006 | ADMET | 11 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | Unchecked | 11 |
| 22753 | 10.1021/jm00199a029 | Mus musculus | 11 |
| 24997576 | 10.1016/j.bmc.2014.06.012 | Mycolicibacterium smegmatis | 11 |
| 42799 | 10.1021/jm00197a021 | Mus musculus | 10 |
| 2891853 | 10.1021/jm00396a016 | Mus musculus | 10 |
| 2571727 | 10.1021/jm00130a003 | Rattus norvegicus | 9 |
| 18765686 | 10.1128/aac.00197-08 | Naegleria fowleri | 9 |
| 20070106 | 10.1021/jm901371v | Homo sapiens | 8 |
| 15646539 | 10.1016/s0399-8320(04)95062-2 | NON-PROTEIN TARGET | 8 |
| 37336 | 10.1021/jm00192a013 | Mus musculus | 8 |
| - | 10.1039/C3MD00387F | Mycolicibacterium smegmatis | 8 |
Data from ChEMBL 36 via Core Engine